What modern crystallography can add to pharmaceutical research?

Krzysztof Woźniak 1,2Maura D. Malińska 1,2Paulina M. Dominiak 1,2Andrzej Kutner 3

1. Uniwersytet Warszawski, Centrum Nowych Technologii (CENT), Żwirki i Wigury 93, Warszawa 02-089, Poland
2. University of Warsaw, Department of Chemistry, Pasteura 1, Warsaw, Warszawa 02-093, Poland
3. Pharmaceutical Research Institute (IF), Rydygiera 8, Warszawa 01-793, Poland

Abstract

More than centuary ago, Max von Laue, William Henry Bragg and William Lawrence Bragg opened the field of structural applications of X-ray diffraction. Since then, the X-ray diffraction methods have been used to establish crystal and molecular structure of more than  milion compounds - among them many of pharmaceutical importance. However, modern crystallography can go far beyond routine crystal structure analysis.

In my contribution, I will discuss pros and cons of classical diffraction methods. Then will present the main ideas of modern methods based on quantitative studies of electron density in crystals. Such methods were introduced by Prof. Philip Coppens (SUNY, Buffalo, USA), who has started a new field of crystallographic and physicochemical research. Quantitave studies of electron density allow for far more detailed characterisation of properties of pharmaceutical substances in the solid state than any other classical X-ray diffraction techniques. My contribution will also cover quantitative relationships between atoms interactiong in crystals, and the role of factors influencing the quality of such relations such as: treatment of h-atoms, assumptions applied during refinement process and importance of neutron data both for charge densities and also for routine structural refinements. I will present relevant examples of such studies.

 I will also discuss the idea of pseudoatom databanks - now being intensively developed in our laboratory by my co-workers - containing the smallest transferable fragments of electron density, which can be used to reconstruct electron density in small molecules and proteins. This allows  to obtain energy of electrostatic interactions between drug molecules and proteins. In most pharmaceutical problems, these are electrostatic interactions which play the crucial role. Thus the methods based on reconstruction of electron density allow for optimisation of drug molecule properties  and design of better drugs. 

 

 

Legal notice
  • Legal notice:

    Copyright (c) Pielaszek Research, all rights reserved.
    The above materials, including auxiliary resources, are subject to Publisher's copyright and the Author(s) intellectual rights. Without limiting Author(s) rights under respective Copyright Transfer Agreement, no part of the above documents may be reproduced without the express written permission of Pielaszek Research, the Publisher. Express permission from the Author(s) is required to use the above materials for academic purposes, such as lectures or scientific presentations.
    In every case, proper references including Author(s) name(s) and URL of this webpage: http://science24.com/paper/31165 must be provided.

 

Related papers
  1. The comparison of the stability indicating  two HPLC methods and their application for the determination of bosentan in coated tablets 
  2. Antiproliferative and cytotoxic effect of vitamin D3 and its derivatives on the selected cells with a higher proliferative potential
  3. Pharmaceutical  technologies  – why do they have to be innovative
  4. A novel convergent synthesis of the prostaglandin F analogues
  5. Comparative permeation studies of tacalcitol through the human skin from brand product versus generic product
  6. Physicochemical characterization of sunitinib and its impurities
  7. Vitamin D analogs enhance the activity of imatinib mesylate in human non-small cell lung cancer model
  8. Colon cancer treatment with the use of vitamin D analogs and irinotecan 
  9. Experimental and theoretical charge density studies on a model analogue of vitamin D
  10. Synthetic Technologies of Pharmaceutical Substances
  11. The influence of (24R)-1,24- dihydroxyvitamin D3 on the anticancer activity of 5-fluorouracil in human colon cancer model
  12. The use of the hyphenated LC-MS/MS technique for the characterisation of impurity profile of Quetiapine during drug development
  13. A novel synthesis of 19-nor analogs of vitamin D
  14. The influence of novel analogs of vitamin D3 on the antiproliferative activity of cisplatin or doxorubicin on human promyelocytic leukaemia cell line HL-60 
  15. Isolation, structural elucidation and characterization of impurities in latanoprost
  16. New rosiglitazone salts
  17. New calcipotriol analogs, their toxicity and antitumor activity in vivo in comparison to the affinity with VDR and DBP
  18. High-yielded method of synthesis of voriconazole.
  19. Redox processes of dithiolated tetraazamacrocyclic complexes of Ni(II) and Cu(II) in solution and immobilized on gold electrodes
  20. Charge Density Studies of Tetraazamacrocyclic Complexes of Copper(II) and Nickel(II)
  21. Polimorphism of Active Pharmaceutical Ingredients
  22. Sigma Cutoff - and What Lies Behind
  23. ANTITUMOR EFFECT OF CISPLATIN OR FLUOROURACIL IN COMBINED TREATMENT WITH (24R)-1,24-DIHYDROXYVITA- MIN D3
  24. COMBINATION OF: IMATINIB, PRI-2191 AND CYTOSTATICS - THE ANTIPROLIFERATIVE EFFECTS ON HL-60 LEUKEMIA CELL LINE
  25. ANTIPROLIFERATIVE ACTIVITY IN VITRO OF DIASTEREOMERIC ANALOGUES OF VITAMIN D3 AGAINST NORMAL AND CANCER CELL LINES
  26. Fine-tuning of properties of bismacrocyclic dinuclear cyclidene receptors by N-methylation.

Presentation: Invited oral at IX Multidyscyplinarna Konferencja Nauki o Leku, by Krzysztof Woźniak
See On-line Journal of IX Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2014-03-18 13:05
Revised:   2014-05-02 19:43
Google
 
Web science24.com
© 1998-2021 pielaszek research, all rights reserved Powered by the Conference Engine